APA

Willemen Y., Van den Bergh J. M. J., Lion E., Anguille S., Roelandts V. A. E., Van Acker H. H., Heynderickx S. D. I., Stein B. M. H., Peeters M., Figdor C. G., Van Tendeloo V. F. I., de Vries I. J., Adema G. J., Berneman Z. N. & Smits E. L. J. (20151023). Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions. : Cancer immunology, immunotherapy : CII.

Chicago

Willemen Yannick, Van den Bergh Johan M J, Lion Eva, Anguille Sébastien, Roelandts Vicky A E, Van Acker Heleen H, Heynderickx Steven D I, Stein Barbara M H, Peeters Marc, Figdor Carl G, Van Tendeloo Viggo F I, de Vries I Jolanda, Adema Gosse J, Berneman Zwi N and Smits Evelien L J. 20151023. Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions. : Cancer immunology, immunotherapy : CII.

Harvard

Willemen Y., Van den Bergh J. M. J., Lion E., Anguille S., Roelandts V. A. E., Van Acker H. H., Heynderickx S. D. I., Stein B. M. H., Peeters M., Figdor C. G., Van Tendeloo V. F. I., de Vries I. J., Adema G. J., Berneman Z. N. and Smits E. L. J. (20151023). Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions. : Cancer immunology, immunotherapy : CII.

MLA

Willemen Yannick, Van den Bergh Johan M J, Lion Eva, Anguille Sébastien, Roelandts Vicky A E, Van Acker Heleen H, Heynderickx Steven D I, Stein Barbara M H, Peeters Marc, Figdor Carl G, Van Tendeloo Viggo F I, de Vries I Jolanda, Adema Gosse J, Berneman Zwi N and Smits Evelien L J. Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions. : Cancer immunology, immunotherapy : CII. 20151023.